ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,819Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 198

$911K Total Retail Price of All Prescriptions

Rank: 11 out of 198

757 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 757 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 757 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 14,795 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 735 660 1 2
AMLODIPINE BESYLATE 689 611 2 4
OMEPRAZOLE 653 507 3 3
LEVOTHYROXINE SODIUM 644 587 4 1
BENAZEPRIL HCL 608 475 5 45
ATORVASTATIN CALCIUM 568 532 6 12
METOPROLOL SUCCINATE 499 472 7 11
FUROSEMIDE 482 422 8 5
POTASSIUM CHLORIDE 413 374 9 9
HYDROCODONE-ACETAMINOPHEN 403 305 S3 10 8
WARFARIN SODIUM 353 326 11 7
LISINOPRIL 320 284 12 6
METOPROLOL TARTRATE 305 260 13 10
METFORMIN HCL 299 249 14 13
CITALOPRAM HBR 276 233 15 20
PRAVASTATIN SODIUM 255 238 16 19
HYDROCHLOROTHIAZIDE 234 204 17 16
GABAPENTIN 224 170 18 14
FLUTICASONE PROPIONATE 193 163 19 39
ALENDRONATE SODIUM 190 170 20 21
MIRTAZAPINE 184 149 21 44
LOSARTAN POTASSIUM 183 166 22 18
ZOLPIDEM TARTRATE 183 146 22 22
DONEPEZIL HCL 165 165 24 28
PANTOPRAZOLE SODIUM 157 134 25 31
SERTRALINE HCL 156 132 26 25
NEXIUM 155 131 27 40
CLONIDINE HCL 141 135 28 52
ALLOPURINOL 140 122 29 23
BENAZEPRIL-HYDROCHLOROTHIAZIDE 139 129 30 155
GLIMEPIRIDE 131 123 31 35
TRAMADOL HCL 127 97 32 15
BYSTOLIC 124 122 33 58
ADVAIR DISKUS 120 104 34 47
CRESTOR 117 117 35 26
CELEBREX 116 96 36 59
SYNTHROID 114 97 37 36
ATENOLOL 109 104 38 17
TRIAMTERENE-HCTZ 106 104 39 32
FENOFIBRATE 103 98 40 61
TAMSULOSIN HCL 100 93 41 27
NAMENDA 98 98 42 33
CIPROFLOXACIN HCL 98 90 42 55
PREDNISONE 97 66 44 29
CLOPIDOGREL 94 78 45 42
FLUOXETINE HCL 86 56 46 78
KLOR-CON M20 81 81 47 137
LIPITOR 78 68 48 116
AZITHROMYCIN 77 63 49 56
DOXYCYCLINE HYCLATE 75 62 50 97
OXYCODONE HCL 75 0 S2 50 112
FINASTERIDE 73 73 52 94
ACTOS 73 61 52 115
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 70 52 38
CYCLOBENZAPRINE HCL 72 41 R 55 67
RANITIDINE HCL 71 48 56 54
CARVEDILOL 68 65 57 24
SPIRIVA 64 56 58 63
FENTANYL 62 40 S2 59 73
PLAVIX 62 52 59 66
LANTUS 59 37 61 46
TRICOR 59 46 61 93
NYSTATIN 57 48 63 148
ROPINIROLE HCL 56 42 64 74
DIGOXIN 55 55 65 43
HUMULIN 70-30 53 43 66 192
VESICARE 53 53 66 77
OXYCODONE-ACETAMINOPHEN 52 33 S2 68 79
PROAIR HFA 52 36 68 80
ZETIA 51 41 70 68
PEN NEEDLE 51 45 70 114
BENICAR 51 51 70 100
LOSARTAN-HYDROCHLOROTHIAZIDE 50 47 73 49
CYMBALTA 50 26 73 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.